An interventional study of SIJ fusion with iFuse-3D in Sacroiliac Dysfunction, sponsored by SI-BONE, Inc.. Completed at 11 sites in United States. Open to participants aged 21 Years to 70 Years. Per ClinicalTrials.gov, last updated 2025-06-05.
Sponsored by SI-BONE, Inc. · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
SALLY studies sacroiliac joint fusion with the iFuse-3D implant.
Participants will all get sacroiliac joint fusion on this study using the iFuse-3D titanium implant, manufactured by SI-BONE, Inc. Participants will be followed for clinical outcomes at pre-planned time points on the trial. Participants will be randomized to CT scan at 6 months or 12 months, and all will also get a CT scan at 5 years, the final visit for the study.
SI-BONE, Inc. is the lead sponsor of 13 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Diagnosis of sacroiliac joint dysfunction on one or two sides to be treated on study that is a direct result of sacroiliac joint disruption and/or degenerative sacroiliitis and is based on ALL of the following:
Exclusion Criteria:
SI joint dysfunction due to an alternative explanation such as:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A drug or device being studied in a clinical trial.
It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Investigational drug or device
A drug or device being studied in a clinical trial.
It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
These subjects will get pelvic CT at 6 months post-operatively.
Device: SIJ fusion with iFuse-3D
These subjects will get pelvic CT at 12 months post-operatively.
Device: SIJ fusion with iFuse-3D
Minimally invasive SIJ fusion with iFuse-3D titanium implant (usually 3 implants per SIJ).
Primary Radiographic Outcome: Bone adherence
Percent surface area of the sacral end of the implants to which bone is adherent.
Time frame: Comparing 6 and 12 month CTs to historical data from other studies.
Primary Clinical Outcome: Disability due to low back pain
Improvement in Oswestry Disability Index
Time frame: Comparing baseline to 6 months.
Bridging Bone
Proportion of treated SIJs with bridging bone.
Time frame: 6 months, 12 months, and 5 years
Clinically Significant Radiolucency
Proportion of treated SIJs with evidence of clinically significant radiolucency.
Time frame: 6 months, 12 months, and 5 years
Adverse Bone Reactions
Proportion of treated SIJs with adverse bone reactions at or near the SIJ.
Time frame: 6 months, 12 months, and 5 years
Positive Bone Remodeling
Proportion of treated SIJs with positive bone remodeling response.
Time frame: 6 months, 12 months, and 5 years
SIJ Pain
Improvement from baseline in SIJ pain as measured by Visual Analog Scale
Time frame: Baseline, 3 mo, 6 mo, 12 mo, 24 mo, 60 months.
Disability
Improvement from baseline in disability as measured by Oswestry Disability Index.
Time frame: Baseline, 3 mo, 6 mo, 12 mo, 24 mo, 60 months.
QOL
Improvement from baseline in QOL as measured by EQ-5D
Time frame: Baseline, 3 mo, 6 mo, 12 mo, 24 mo, 60 months.
Physical Function
Improvement from baseline in physical function as measured by active straight leg raise, 5 times sit to stand, transitional timed up and go.
Time frame: Baseline, 3 mo, 6 mo, 12 mo, 24 mo, 60 months.
Opioid Use
Decrease from baseline in opioid use
Time frame: Baseline, 3 mo, 6 mo, 12 mo, 24 mo, 60 months.
Serious Adverse Event Rate
Rate of serious adverse events related to the procedure or device.
Time frame: 3 mo, 6 mo, 12 mo, 24 mo, 60 months.
Plan to share: Undecided
No publications or documents are linked to this record.
Ran from Oct 2017 to primary completion in Jun 2024, 80 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
SI-BONE, Inc.